PCM Trials - Quality Mobile Research

Background

PCM Trials, a division of Professional Case Management, is a leader in decentralized clinical trials (DCTs), specializing in delivering clinical research directly to patients through Certified Mobile Research Nurses (CMRNs). Established in 2008 and headquartered in Denver, Colorado, PCM Trials aims to make clinical trial participation more convenient, thereby accelerating the approval of new therapies. The company's mission is to reduce barriers to participation, enhance patient retention, and improve data quality by bringing research to individuals wherever and whenever it is most convenient for them.

Key Strategic Focus

PCM Trials focuses on:

Decentralized Clinical Trials (DCTs): Utilizing CMRNs to conduct clinical research visits in patients' homes or workplaces, thereby increasing accessibility and convenience.

Patient-Centric Approaches: Reducing the burden of study participation to improve recruitment, retention, adherence, and diversity.

Global Reach: Expanding services to over 80 countries, enabling a broader range of patients to participate in clinical trials.

Financials and Funding

Specific financial details and funding history for PCM Trials are not publicly disclosed. However, the company's strategic acquisitions and global expansion indicate a robust financial position and a commitment to growth in the decentralized clinical trial sector.

Pipeline Development

While PCM Trials does not develop its own therapeutic products, it plays a crucial role in the clinical trial process by facilitating the collection of high-quality data through its mobile research services. The company has supported over 150 sponsors and more than 300 protocols across various therapeutic areas.

Technological Platform and Innovation

PCM Trials distinguishes itself through:

Certified Mobile Research Nurse (CMRN) Program: A proprietary certification program ensuring that nurses are trained to meet the highest standards for data quality and patient experience.

Integration of Technology: Successfully integrating Workday and Azure Sentinel to proactively manage and protect data, enhancing cybersecurity measures.

Leadership Team

Greg Austin, President: Leads PCM Trials with a focus on expanding decentralized clinical trials and enhancing patient-centric approaches. Under his leadership, the company has achieved significant growth and global expansion.

Leadership Changes

Recent leadership changes include:

Acquisition of Clinical Trial Service (CTS): In January 2024, PCM Trials acquired CTS, with founder Mirjam Bruggink remaining with the company to ensure a smooth transition and continued operations.

Acquisition of EmVenio Research: In February 2024, PCM Trials acquired EmVenio Research, with President Thad Wolfram continuing to lead EmVenio under the PCM Trials umbrella.

Competitor Profile

Market Insights and Dynamics

The decentralized clinical trial market is experiencing significant growth, driven by the need for more patient-centric approaches and the impact of the COVID-19 pandemic, which highlighted the importance of remote and flexible clinical trial solutions.

Competitor Analysis

Key competitors include:

Science 37: Specializes in virtual clinical trials, offering a technology platform that enables remote participation.

Medable: Provides a decentralized trial platform focusing on patient engagement and data management.

ICON plc: A global provider of outsourced development and commercialisation services to the pharmaceutical industry, including DCT capabilities.

Strategic Collaborations and Partnerships

PCM Trials has strengthened its market position through strategic acquisitions:

Clinical Trial Service (CTS): Acquired in January 2024, expanding PCM Trials' global footprint and enhancing its ability to conduct international DCTs.

EmVenio Research: Acquired in February 2024, providing access to community-based clinical trial sites and mobile research units, thereby improving recruitment and retention of diverse populations.

Operational Insights

PCM Trials' direct employment and certification of mobile research nurses ensure high-quality data collection and patient safety. The company's global reach and patient-centric approach provide a competitive advantage in the DCT market.

Strategic Opportunities and Future Directions

PCM Trials is poised to:

Expand Global Reach: Continue growing its presence in international markets to support global clinical trials.

Enhance Technological Integration: Further integrate advanced technologies to improve data management and cybersecurity.

Increase Patient Diversity: Focus on recruiting and retaining diverse patient populations to meet regulatory requirements and improve trial outcomes.